InvestorsHub Logo
Followers 12
Posts 260
Boards Moderated 0
Alias Born 11/17/2020

Re: learningcurve2020 post# 358883

Tuesday, 03/02/2021 2:47:51 PM

Tuesday, March 02, 2021 2:47:51 PM

Post# of 692418
This is a confusing statement to me as well. She definitely seems jaded by the clinical trial process, and it's also a reasonable inference to conclude that she's become jaded with NWBO specifically. Her statement regarding NWBO's patent strategy certainly suggests that she's not a fan of the company. But is that really all that surprising? She's trying to cure cancer, not make money. I think it's safe to say that Dr. Liau is the most frustrated person in the world over the delay in getting DCVAX-L approved...she's bound to place at least some of the blame for the delay on NWBO, rightly or wrongly. And as others have pointed out, she's not a patent attorney. So even though she may have some kind of moral objection to NWBO's patent strategy, that doesn't invalidate their existing patents.

At the end of the day, I think what she's getting at is that DCVAX-L is not a cure for most people and thus, her mission is not complete and she's still searching for an answer. However, if DCVAX-L is a cure for some people, and if it extends life in enough other people, then DCVAX-L will get approved and if the patient population is large enough, it will be a home run financially, especially if it works for other indications, which it should.

Fun fact of the day: Malloy's wife is still alive 2 years after her diagnosis, which is 16 months longer than she was originally told she had to live. How wonderful for the Malloy family! I pray that she continues to stay healthy.



Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News